The Pharmaceutical Compliance Forum's 23rd Pharmaceutical & Medical Device Ethics and Compliance Congress Announces Agenda-at-a-Glance & OIG Senior Counsel Mary Riordan, JD Keynote Address
  • A Hybrid Onsite Conference and Internet Event
  • Sponsored by Pharmaceutical Compliance Forum
  • Media Partners: Policy & Medicine Compliance Update
  • October 24-26, 2022
  • Capitol Hyatt, Washington, DC
  • www.PharmaCongress.com

PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com

FEATURING KEYNOTE ADDRESS BY

Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC
REGISTER BY 8/26 FOR EARLY BIRD RATE
Click Here for discounted registration.
AGENDA-AT-A-GLANCE NOW AVAILABLE
Click Here for Agenda-at-a-Glance..
FEATURING
  • We are thrilled to welcome you back to Washington DC for the in-person/hybrid PCF Congress!
  • Join us live to take advantage of numerous interpersonal networking opportunities with colleagues and educational opportunities at our robust exhibit hall with our industry partners
  • An invitation-only, closed-door Chief Compliance Officer (CCO) Roundtable on the morning of Tuesday, October 25 For more information contact pcf.org.info@gmail.com.
  • Annual reports and updates provided by DOJ, FDA, and OIG
  • Over 30 current topics addressing crucial ethics, compliance and legal issues
  • An industry-only, closed-door session for pharma and device ethics, compliance and legal professionals on Wednesday, October 26

WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- AUGUST 8, 2022: The Pharmaceutical Compliance Forum (PCF) executive committee is pleased to announce that the Twenty-Third Pharmaceutical & Medical Device Ethics and Compliance Congress is returning to the Hyatt Regency on Capitol Hill in Washington, DC on October 24-26, 2022.

NEWLY CONFIRMED KEYNOTE SPEAKERS

Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD

Glenn Leon, JD
Incoming Fraud Section Chief, Criminal Division, US Department of Justice; Former SVP & Chief Ethics & Compliance Officer, Hewlett Packard, Washington, DC

Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC

Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, HHS Office of Counsel to the Inspector General, Washington, DC

Jamie Yavelberg, JD
Director, Fraud Section, Civil Division, US Department of Justice, Washington, DC

FEATURED FACULTY

Meredith S. Auten, JD
Partner, Morgan, Lewis & Bockius LLP

Kristiana Bankova, MS
Senior Manager Forensics, EY

Samantha Barrett Badlam, JD
Counsel, Ropes & Gray

Eric M. Baim, MA, JD
Partner, Dovetail Consulting Group LLC; Former VP Compliance US, Shire

Ann E. Beasley, JD
Chief Compliance Officer, Zai Lab

Allison Benkert, MBA
Director Global Compliance Investigations, Seagen

Jennifer Bragg, JD
Partner, Skadden Arps LLP

Adam L. Braverman, JD
Partner, Morrison & Foerster, Former US Attorney, Southern District of California

Terra Buckley, JD
VP, Head of Compliance Advisory Services, MedPro Systems; VP Compliance, Mesoblast

Craig Carpenito, JD
Partner, King & Spalding; Former US Attorney, New Jersey

Steven Cohen, MBA
Associate Vice President & Chief Ethics and Compliance Officer, North America and Canada, Eli Lilly

Jake DeBoever, JD
Vice President, Chief Compliance Officer, Dermavant Sciences

Gildas Durand
Partner/Principal, Forensic & Integrity Services, EY

David Falcone
Associate Vice President Global Compliance, Merz Aesthetics

J. Mark Farrar, CPA, CFE, CFF, MSJ, CIPP/US
Managing Director, Epsilon Life Sciences LLC

Bethany Fox, JD
Vice President, Commercial Legal Affairs, Exelixis

Sara Frank, JD
Principal, Choate, Hall & Stewart LLP

Nereyda Garcia, JD
Head, Ethics & Compliance, US Business Unit, Takeda

Gary F. Giampetruzzi, JD
Partner, Paul Hastings

Edward P. Glynn, MBA
Principal, EY

Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, USDOJ

Tom Gregory
Partner, Forensic & Integrity Services, EY

Noor Haq, CCEP, MS, MBA, CIA
Executive Director, US Compliance, Amgen

Saul B. Helman MD, MBA
President, Epsilon Life Sciences

Michael Hercz, JD
SVP & General Counsel, Sentynl

Emily F. Hodge, JD
Partner, Choate, Hall & Stewart LLP

Andrea Kocharyan, JD
Vice President, Head of Legal and Compliance, Zealand Pharma

Daniel Koerner
Senior Director, Potomac River Partners

Michael K. Loucks, JD
Partner, Skadden Arps LLP; Former Acting US Attorney, Massachusetts, DOJ

Seth H. Lundy, JD
Partner, FDA and Life Sciences, King & Spalding

Jim Massey, MS
Chief Sustainability Officer, Zai Lab

Chris Matteson
Senior Manager, EY

Kirstin Mayer, JD
Head of US Compliance, Argenx

Gregory F. Noonan, JD
Partner, Hogan Lovells; Former AUSA, Massachusetts & Southern District of California

Katherine Norris, MPA
Managing Director, Epsilon Life Sciences

Kristen Oberg, JD
Senior Vice President, Legal & Compliance, Mycovia Pharmaceuticals

Chelsea Ott, JD
Director, Global Regulatory, MedPro Systems

Danielle Pelot, JD
Partner, Choate, Hall & Stewart LLP

Zoe Philippides, JD
Senior Vice President, Chief Ethics, Compliance & Privacy Officer, Moderna

Susan Pietras
Global Head of Training, Communication and Policies CHC, Sanofi

Lawrence P. Platkin, JD
Vice President and Head, U.S. Office of Compliance, Bayer US

Nikki Reeves, JD
Partner & Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding

Howard Root, JD
Chairman, Reprise Biomedical; Former, CEO & Co-Founder, Vascular Solutions

Jeff Rosenbaum, MBA
Partner & Co-Founder, Dovetail Consulting Group

Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory

Tim Slone, MS, HCCP
Vice President, Global Compliance, Novavax

Kaarthick Subramanian, MBA
Vice President, Security and Privacy, ComplyScore; Vice President, Atlas Systems

Kelly J. Tope, JD, MBA
Head of USBU Ethics & Compliance Monitoring and Reporting Operations, Takeda

Annalisa Torrente-Haney, MS
Associate Director, Contract to Pay Operations US Business Partner, AstraZeneca

Beth P. Weinman, JD
Counsel, Ropes & Gray; Former Associate Chief Counsel, FDA

Justin Will, JD
Global Commercial Compliance Consulting & Managed Services Practice Leader, IQVIA

Ronald L. Wisor, Jr, JD
Partner, Hogan Lovells


SPONSORED BY

The Pharmaceutical Compliance Forum (PCF) is a coalition of compliance professionals including compliance officers and senior legal counsels from 100+ distinguished researched-based pharmaceutical manufacturers and biotech companies.

GRANTORS
GOLD


SILVER









BRONZE




























MEDIA PARTNERS:




TUITION SCHOLARSHIPS:
The Pharma & Medical Device Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those who have lost their jobs as a result of the COVID-19 pandemic.

Click here for more information.
PCF EXECUTIVE COMMITTEE

Joe Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics
(PCF Chair)

Christie Camelio
Chief Compliance and Risk Officer, EQRx

Jill Dailey, JD
Vice President & Chief Compliance Officer, Incyte

Joshua Marks, JD
Vice President, Chief Ethics & Compliance Officer, Boehringer Ingelheim

Margaret Sparks, JD
Head of Compliance, Vaccines & North America Ethics and Business Integrity, Sanofi

Donna White, CCEP
Vice President, Compliance, Chiesi

MEDICAL DEVICE STEERING COMMITTEE CO CHAIRS

Sujata Dayal, JD
Vice President & Global Chief Compliance Officer, Medline Industries, Inc.

Tara Shewchuk, JD
Chief Ethics & Compliance Officer, Medtronic

Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker

CONGRESS REGISTRATION
For Congress registration information, visit https://www.pharmacongress.com/registration-splash/, email reginfo@hcconferences.com, or call 800-503-7419.

CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
For sponsorship and exhibit information contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.

FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.

For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.